Metabolismus bilirubinu a jeho biologické účinky

1. Tenhunen, R., Marver, H. S., Schmid, R. Enzymatic Conversion of Heme to Bilirubin by Microsomal Heme Oxygenase. Proc. Natl. Acad. Sci. USA 1968, 61, p. 748-755.

2. Baranano, D. E., Rao, M., Ferris, C. D., Snyder, S. H. Biliverdin reductase: A major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA 2002, 99, p. 16093-16098.

3. Yamaguchi, T., Nakajima, H. Changes in the Composition of Bilirubin-Ix Isomers during Human Prenatal Development. Eur. J Biochem. 1995, 233, p. 467-472.

4. Ostrow, J. D., Mukerjee, P., Tiribelli, C. Structure and binding of unconjugated bilirubin: relevance for physio-logical and pathophysiological function. J Lipid Res. 1994, 35, p. 1715-1737.

5. Jacobsen, J. Binding of bilirubin to human serum albumin - determination of the dissociation constants. FEBS Lett 1969, 5, p. 112-114.

6. Adachi, Y., Kamisako, T., Okuyama, Y., Miya, H. Hepatic metabolism and transport of bilirubin and other organic anions. Nihon Rinsho 1996, 54, p. 2276-2290.

7. Vander Jagt, D. L., Dean, V. L., Wilson, S. P., Royer, R. E. Regulation of the glutathione S-transferase activity of bilirubin transport protein (ligandin) from human liver. Enzymic memory involving protein-protein interactions. J Biol. Chem. 1983, 258, p. 5689-5694.

8. Crawford, J. M., Hauser, S. C., Gollan, J. L. Formation, hepatic metabolism, and transport of bile pigments: a status report. Semin. Liver Dis. 1988, 8, p. 105-118.

9. Kamisako, T., Leier, I., Cui, Y. et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999, 30, p. 485-490.

10. van de Steeg, E., Stranecky, V., Hartmannova, H. et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjuga-ted bilirubin reuptake into the liver. J Clin. Invest. 2012, 122, p. 519-528.

11. Gartner, U., Goeser, T., Wolkoff, A. W. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 1997, 113, p. 1707-1713.

12. Diamond, I. F. Studies on the neurotoxicity of bilirubin and the distribution of its derivatives. Birth Defects Res. 1970, 6, p. 124-127.

13. McDonagh, A. F., Lightner, D. A. ‘Like a shrivelled blood orange’--bilirubin, jaundice, and phototherapy. Pediatrics 1985, 75, p. 443-455.

14. Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., Ames, B. N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235, p. 1043-1046.

15. Kwak, J. Y., Takeshige, K., Cheung, B. S., Minakami, S. Bilirubin inhibits the activation of superoxide-producing nadph oxidase in a neutrophil cell-free system. Biochim Biophys Acta 1991, 1076, p. 369-373.

16. Stocker, R., Ames, B. N. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc. Natl. Acad. Sci. U S A 1987, 84, p. 8130-8134.

17. Wu, T. W., Fung, K. P., Yang, C. C. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 1994, 54, p. 477-481.

18. Schwertner, H. A., Jackson, W. G., Tolan, G. Association of low serum concentration of bilirubin with increased risk of coronary-artery disease. Clin. Chem. 1994, 40, p. 18-23.

19. Peng, F., Deng, X., Yu, Y. et al. Serum bilirubin concentrations and multiple sclerosis. J Clin. Neurosci. 2011, 18, p. 1355-1359.

20. Lin, J. P., Vitek, L., Schwertner, H. A. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin. Chem. 2010, 56, p. 1535-1543.

21. Novotny, L., Vitek, L. Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies. Exp. Biol. Med. 2003, 228, p. 568-571.

22. Petrovic, V., Teng, S., Piquette-Miller, M. Regulation of drug transporters during infections and inflammation. Molecular Interventions 2007, 7, p. 99-111.

23. Siebenlist, U., Franzoso, G., Brown, K. Structure, regulation and function of Nf-Kappa-B. Annu. Rev. Cell. Biol. 1994, 10, p. 405-455.

24. Liu, Y., Li, P., Lu, J. et al. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol. 2008, 181, p. 1887-1897.

25. Soares, M. P., Seldon, M. P., Gregoire, I. P. et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004, 172, p. 3553-3563.

26. Sidel, N. A. Jaundice in arthritis: its analgesic action. N Engl. J Med. 1934, 210, p. 181-182.

27. Lenicek, M., Duricova, D., Hradsky, O. et al. The relationship between serum bilirubin and Crohn´s disease. Inflamm. Bowel. Dis. 2014, 20, p. 481-7.

28. Vitek, L., Muchova, L., Jancova, E. et al. Association of systemic lupus erythematosus with low serum bilirubin levels. Scand. J Rheumatol. 2010, 39, p. 480-484.

29. Fischman, D., Valluri, A., Gorrepati, V. S., Murphy, M. E., Peters, I., Cheriyath, P. Bilirubin as a protective factor for rheumatoid arthritis: An NHANES study of 2003 - 2006 Data. J Clin. Med. Res. 2010, 2, p. 256-260.

30. Nejedla, Z. The development of immunological factors in infants with hyperbilirubinemia. Pediatrics 1970, 45, p. 102-104.

31. Vetvicka, V., Miler, I., Sima, P., Taborsky, L., Fornusek, L. The effect of bilirubin on the Fc receptor expression and phagocytic activity of mouse peritoneal macrophages. Folia Microbiol. 1985, 30, p. 373-380.

32. Jangi, S., Otterbein, L., Robson, S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Int. J Biochem. Cell Biol. 2013, 45, p. 2843-2851.

33. Adachi, K., Fukumoto, S. Inflammatory polyp of the extra-hepatic bile duct. Ryoikibetsu Shokogun Shirizu 1996, p. 149-151.

34. Vogel, M., Idelman, G., Zucker, S. Bilirubin inhibits the transmigration of monocytes across endothelial cell monolayers: implications for atherosclerosis prevention. Faseb J 2015, 29.

35. Keshavan, P., Deem, T. L., Schwemberger, S. J., Babcock, G. F., Cook-Mills, J. M., Zucker, S. D. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol. 2005, 174, p. 3709-3718.